🇺🇸English

GWAS Study Deep Dive & Meta-Analysis

Compare GWAS studies, perform meta-analyses, and assess replication across cohorts

Overview

The GWAS Study Deep Dive & Meta-Analysis skill enables comprehensive comparison of genome-wide association studies (GWAS) for the same trait, meta-analysis of genetic loci across studies, and systematic assessment of replication and study quality. It integrates data from the NHGRI-EBI GWAS Catalog and Open Targets Genetics to provide a complete picture of the genetic architecture of complex traits.

Key Capabilities

1. Study Comparison : Compare all GWAS studies for a trait, assessing sample sizes, ancestries, and platforms
2. Meta-Analysis : Aggregate effect sizes across studies and calculate heterogeneity statistics
3. Replication Assessment : Identify replicated vs novel findings across discovery and replication cohorts
4. Quality Evaluation : Assess statistical power, ancestry diversity, and data availability

Use Cases

1. Comprehensive Trait Analysis

Scenario : "I want to understand all available GWAS data for type 2 diabetes"

Workflow :

• Search for all T2D studies in GWAS Catalog
• Filter by sample size and ancestry
• Extract top associations from each study
• Identify consistently replicated loci
• Assess ancestry-specific effects

Outcome : Complete landscape of T2D genetics with replicated findings and population-specific signals

2. Locus-Specific Meta-Analysis

Scenario : "Is the TCF7L2 association with T2D consistent across all studies?"

Workflow :

• Retrieve all TCF7L2 (rs7903146) associations for T2D
• Calculate combined effect size and p-value
• Assess heterogeneity (I² statistic)
• Generate forest plot data
• Interpret heterogeneity level

Outcome : Quantitative assessment of effect size consistency with heterogeneity interpretation

3. Replication Analysis

Scenario : "Which findings from the discovery cohort replicated in the independent sample?"

Workflow :

• Get top hits from discovery study
• Check for presence and significance in replication study
• Assess direction consistency
• Calculate replication rate
• Identify novel vs failed replication

Outcome : Systematic replication report with success rates and failed findings

4. Multi-Ancestry Comparison

Scenario : "Are T2D loci consistent across European and East Asian populations?"

Workflow :

• Filter studies by ancestry
• Compare top associations between populations
• Identify shared vs population-specific loci
• Assess allele frequency differences
• Evaluate transferability of genetic risk scores

Outcome : Ancestry-specific genetic architecture with transferability assessment

Statistical Methods

Meta-Analysis Approach

This skill implements standard GWAS meta-analysis methods:

Fixed-Effects Model :

• Used when heterogeneity is low (I² < 25%)
• Weights studies by inverse variance
• Assumes true effect size is the same across studies

Random-Effects Model (recommended when I² > 50%):

• Accounts for between-study variation
• More conservative than fixed-effects
• Better for diverse ancestries or methodologies

Heterogeneity Assessment :

The I² statistic measures the percentage of variance due to between-study heterogeneity:

I² = [(Q - df) / Q] × 100%

where Q = Cochran's Q statistic
      df = degrees of freedom (n_studies - 1)

Interpretation Guidelines :

• I² < 25%: Low heterogeneity → fixed-effects appropriate
• I² = 25-50% : Moderate heterogeneity → investigate sources
• I² = 50-75% : Substantial heterogeneity → random-effects preferred
• I² > 75%: Considerable heterogeneity → meta-analysis may not be appropriate

Sources of Heterogeneity

Common reasons for high I²:

1. Ancestry differences : Different allele frequencies and LD structure
2. Phenotype heterogeneity : Trait definition varies across studies
3. Platform differences : Imputation quality and coverage
4. Winner's curse : Discovery studies overestimate effect sizes
5. Cohort characteristics : Age, sex, environmental factors

Recommendations :

• Perform subgroup analysis by ancestry
• Use meta-regression to investigate sources
• Consider excluding outlier studies
• Apply genomic control correction

Study Quality Assessment

Quality Metrics

The skill evaluates studies based on:

1. Sample Size :

• Power to detect associations (80% power requires n > 10,000 for OR=1.2)
• Precision of effect size estimates
• Ability to detect modest effects

2. Ancestry Diversity :

• Single-ancestry vs multi-ancestry
• Population stratification control
• Transferability of findings

3. Data Availability :

• Summary statistics available for meta-analysis
• Individual-level data vs summary-level
• Imputation quality scores

4. Genotyping Quality :

• Platform density and coverage
• Imputation reference panel
• Quality control measures

5. Statistical Rigor :

• Genome-wide significance threshold (p < 5×10⁻⁸)
• Multiple testing correction
• Replication in independent cohort

Quality Tiers

Tier 1 (High Quality) :

• n ≥ 50,000
• Summary statistics available
• Multi-ancestry or large single-ancestry
• Imputed to high-quality reference
• Independent replication

Tier 2 (Moderate Quality) :

• n ≥ 10,000
• Standard GWAS platform
• Adequate power for common variants
• Some data availability

Tier 3 (Limited) :

• n < 10,000
• Limited power
• May miss modest effects
• Use with caution

Best Practices

Before Meta-Analysis

1. Check phenotype consistency : Ensure studies measure the same trait
2. Verify ancestry overlap : High heterogeneity expected if ancestries differ
3. Harmonize alleles : Align effect alleles across studies
4. Quality control : Exclude low-quality studies or associations

Interpreting Results

1. Genome-wide significance : p < 5×10⁻⁸ (Bonferroni for ~1M independent tests)
2. Replication threshold : p < 0.05 in independent cohort
3. Direction consistency : Effect should be same direction across studies
4. Heterogeneity : I² > 50% suggests caution in interpretation

Common Pitfalls

❌ Don't :

• Meta-analyze without checking heterogeneity
• Ignore ancestry differences
• Over-interpret nominal p-values
• Assume replication failure means false positive

✅ Do :

• Always report I² statistic
• Perform sensitivity analyses
• Consider ancestry-stratified analysis
• Account for winner's curse in discovery studies

Limitations & Caveats

Data Limitations

1. Incomplete Overlap : Studies may analyze different SNPs
2. Cohort Overlap : Some cohorts participate in multiple studies (inflates significance)
3. Publication Bias : Significant findings more likely to be published
4. Winner's Curse : Discovery studies overestimate effect sizes
5. Imputation Quality : Varies across studies and populations

Statistical Limitations

1. Heterogeneity : High I² may preclude meaningful meta-analysis
2. Sample Size Differences : Large studies dominate fixed-effects models
3. Allele Frequency Differences : Same variant has different effects across ancestries
4. Linkage Disequilibrium : Fine-mapping needed to identify causal variants
5. Gene-Environment Interactions : Not captured in standard meta-analysis

Interpretation Guidelines

When I² > 75%:

• Meta-analysis results should be interpreted with extreme caution
• Investigate sources of heterogeneity systematically
• Consider ancestry-specific or subgroup analyses
• Descriptive comparison may be more appropriate than meta-analysis

When Studies Conflict :

• Check for methodological differences
• Verify phenotype definitions match
• Investigate population stratification
• Consider conditional analysis

Scientific References

Key Publications

1. GWAS Best Practices :

   • Visscher et al. (2017). "10 Years of GWAS Discovery" American Journal of Human Genetics 101(1): 5-22
   • PMID: 28686856
   • DOI: 10.1016/j.ajhg.2017.06.005

2. Meta-Analysis Methods :

   • Evangelou & Ioannidis (2013). "Meta-analysis methods for genome-wide association studies and beyond" Nature Reviews Genetics 14: 379-389
   • PMID: 23657481

3. Heterogeneity Interpretation :

   • Higgins et al. (2003). "Measuring inconsistency in meta-analyses" BMJ 327: 557-560
   • PMID: 12958120

4. Multi-Ancestry GWAS :

   • Peterson et al. (2019). "Genome-wide Association Studies in Ancestrally Diverse Populations" Nature Reviews Genetics 20: 409-422
   • PMID: 30926972

5. Replication Standards :

   • Chanock et al. (2007). "Replicating genotype-phenotype associations" Nature 447: 655-660
   • PMID: 17554299

Tools Used

GWAS Catalog API

• gwas_search_studies: Find studies by trait
• gwas_get_study_by_id: Get detailed study metadata
• gwas_get_associations_for_study: Retrieve study associations
• gwas_get_associations_for_snp: Get SNP associations across studies
• gwas_search_associations: Search associations by trait

Open Targets Genetics GraphQL API

• OpenTargets_search_gwas_studies_by_disease: Disease-based study search
• OpenTargets_get_gwas_study: Detailed study information with LD populations
• OpenTargets_get_variant_credible_sets: Fine-mapped loci for variant
• OpenTargets_get_study_credible_sets: All credible sets for study
• OpenTargets_get_variant_info: Variant annotation and allele frequencies

Glossary

Association : Statistical relationship between a genetic variant and a trait

Credible Set : Set of variants likely to contain the causal variant (from fine-mapping)

Effect Size : Magnitude of genetic association (beta coefficient or odds ratio)

Fine-Mapping : Statistical method to identify causal variants within a locus

Genome-Wide Significance : p < 5×10⁻⁸, accounting for ~1M independent tests

Heterogeneity (I²) : Percentage of variance due to between-study differences

L2G (Locus-to-Gene) : Score predicting which gene is affected by a GWAS locus

LD (Linkage Disequilibrium) : Non-random association of alleles at different loci

Meta-Analysis : Statistical combination of results from multiple studies

Replication : Independent confirmation of an association in a new cohort

Summary Statistics : Per-SNP statistics (p-value, beta, SE) from GWAS

Winner's Curse : Overestimation of effect size in discovery studies

Next Steps

After running this skill, consider:

1. Fine-Mapping : Use credible sets from Open Targets to identify causal variants
2. Functional Follow-Up : Investigate biological mechanisms of replicated loci
3. Genetic Risk Scores : Calculate polygenic risk scores using validated loci
4. Drug Target Identification : Use L2G scores to prioritize therapeutic targets
5. Cross-Trait Analysis : Look for pleiotropy with related traits

Version History

• v1.0 (2026-02-13): Initial release with study comparison, meta-analysis, and replication assessment

Created by : ToolUniverse GWAS Analysis Team Last Updated : 2026-02-13 License : Open source (MIT)

Weekly Installs

119

Repository

mims-harvard/to…universe

GitHub Stars

1.2K

First Seen

Feb 20, 2026

Security Audits

Gen Agent Trust HubPassSocketPassSnykPass

Installed on

codex117

opencode115

github-copilot114

gemini-cli114

kimi-cli112

amp112